Investigator
Derrick E Fouts
J. CRAIG VENTER INSTITUTE, INC. · funded by NIAID, NCEZID
- Companies
- 2
- Grants
- 3
- Non-dilutive funding
- $2.2M
- First award
- Jun 1, 2021
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jul 21, 2023.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- J. CRAIG VENTER INSTITUTE, INC.Momentum in another area
ImmunologyGrant-only
- J. CRAIG VENTER INSTITUTE, INC.Momentum in another area
Grant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Optimization, Manufacturing and Testing of a Lead Therapeutic Bacteriophage Cocktail for the Treatment of Antibiotic-Resistant Klebsiella pneumoniae Infections
$1.1MJul 21, 2023NIAIDJ. CRAIG VENTER INSTITUTE, INC.NIH RePORTER · 11122247 (opens the source filing in a new tab)
- U54
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter
$590kJun 1, 2021NCEZIDJ. CRAIG VENTER INSTITUTE, INC.NIH RePORTER · 11175952 (opens the source filing in a new tab)
- U54
CK20-004, J. Craig Venter Insitute and Cleveland VA Prevention and Intervention Epicenter
$590kJun 1, 2021NCEZIDJ. CRAIG VENTER INSTITUTE, INC.NIH RePORTER · 11549952 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources